Gedske Daugaard Selected Research

Neutropenia

1/2020	Development and validation of a cycle-specific risk score for febrile neutropenia during chemotherapy cycles 2-6 in patients with solid cancers: The CSR FENCE score.
1/2015	Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gedske Daugaard Research Topics

Disease

36	Neoplasms (Cancer) 01/2024 - 11/2002
28	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 11/2023 - 07/2002
24	Testicular Neoplasms (Testicular Cancer) 01/2024 - 11/2002
19	Prostatic Neoplasms (Prostate Cancer) 06/2023 - 01/2014
12	Seminoma 10/2021 - 04/2006
10	Carcinoma (Carcinomatosis) 01/2024 - 07/2002
9	Neoplasm Metastasis (Metastasis) 10/2021 - 01/2014
6	Disease Progression 01/2023 - 01/2014
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 10/2015
4	Febrile Neutropenia 01/2020 - 10/2018
4	Carcinoma in Situ 11/2009 - 03/2002
3	Nausea 01/2023 - 05/2004
3	Fatigue 01/2023 - 08/2014
3	Infections 02/2020 - 10/2018
2	Residual Neoplasm 01/2024 - 03/2008
2	Ototoxicity 08/2023 - 01/2021
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2022 - 07/2017
2	Neutropenia 01/2020 - 01/2015
2	Vomiting 01/2018 - 05/2004
2	Inflammation (Inflammations) 07/2017 - 08/2011
2	Second Primary Neoplasms (Neoplasms, Second) 10/2015 - 08/2012
2	Cryptorchidism (Undescended Testes) 01/2012 - 04/2006
2	Embryonal Carcinoma 07/2006 - 07/2002
1	Urologic Neoplasms (Urological Cancer) 01/2024
1	Hearing Loss (Hearing Impairment) 08/2023
1	Insulin Resistance 10/2022
1	Adrenocortical Carcinoma 01/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Hypercholesterolemia 01/2020
1	Nonseminomatous germ cell tumor 11/2019
1	Erectile Dysfunction 10/2018
1	Breast Neoplasms (Breast Cancer) 07/2018

Drug/Important Bio-Agent (IBA)

26	Cisplatin (Platino)FDA LinkGeneric 08/2023 - 04/2006
16	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 04/2006
14	Bleomycin (Blenoxane)FDA LinkGeneric 01/2023 - 04/2006
8	Testosterone (Sustanon)FDA Link 08/2023 - 11/2009
6	Prostate-Specific Antigen (Semenogelase)IBA 01/2023 - 10/2014
5	PlatinumIBA 01/2024 - 09/2009
5	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 11/2002
5	Luteinizing Hormone (Lutropin)FDA LinkGeneric 10/2022 - 07/2017
5	MicroRNAs (MicroRNA)IBA 05/2021 - 01/2014
4	rucaparibIBA 01/2023 - 11/2020
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2021 - 01/2020
4	Tumor Biomarkers (Tumor Markers)IBA 11/2019 - 07/2002
4	AndrogensIBA 12/2018 - 11/2002
4	cabazitaxel FDA Link 12/2018 - 06/2014
4	Gemcitabine FDA Link 01/2016 - 05/2010
3	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 08/2023 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 08/2023 - 03/2020
3	Hormones (Hormone)IBA 01/2023 - 04/2012
3	Docetaxel (Taxotere)FDA Link 10/2017 - 06/2013
3	Prednisone (Sone)FDA LinkGeneric 11/2015 - 01/2014
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2012 - 07/2007
2	insulin receptor-related receptor (IRR)IBA 01/2023 - 07/2018
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2021 - 11/2020
2	ORALIT (ORS)IBA 01/2020 - 02/2011
2	Taxoids (Taxanes)IBA 01/2020 - 12/2018
2	taxaneIBA 01/2020 - 10/2014
2	Radium-223IBA 01/2018 - 09/2017
2	AntiemeticsIBA 01/2018 - 05/2004
2	EmeticsIBA 01/2018 - 05/2004
2	Radioisotopes (Radionuclides)IBA 01/2018 - 01/2005
2	Carboplatin (JM8)FDA LinkGeneric 05/2015 - 01/2012
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2015 - 03/2012
2	Messenger RNA (mRNA)IBA 03/2015 - 07/2006
2	Proteins (Proteins, Gene)FDA Link 03/2008 - 07/2006
2	DNA (Deoxyribonucleic Acid)IBA 09/2003 - 11/2002
1	Insulin (Novolin)FDA Link 08/2023
1	A-Form DNA (A-DNA)IBA 01/2023
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2023
1	Mitotane (Lysodren)FDA Link 01/2021
1	LH Receptors (LH Receptor)IBA 05/2020
1	RNA (Ribonucleic Acid)IBA 02/2020
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2020
1	Antidepressive Agents (Antidepressants)IBA 01/2020
1	AlbuminsIBA 10/2018
1	BilirubinIBA 10/2018
1	CreatinineIBA 10/2018
1	Estrogens (Estrogen)FDA Link 07/2018
1	Ondansetron (Zofran)FDA LinkGeneric 01/2018
1	Amisulpride (Solian)IBA 01/2018

Therapy/Procedure

32	Drug Therapy (Chemotherapy) 01/2024 - 07/2002
24	Therapeutics 08/2023 - 08/2010
18	Castration 01/2023 - 01/2014
13	Radiotherapy 06/2023 - 03/2002
9	Orchiectomy (Orchidectomy) 11/2023 - 04/2006
7	Aftercare (After-Treatment) 02/2023 - 08/2011
3	Combination Drug Therapy (Combination Chemotherapy) 01/2023 - 08/2011
2	Ovariectomy (Oophorectomy) 01/2020 - 07/2018
2	Duration of Therapy 01/2020 - 01/2016
2	Resistance Training 08/2014 - 08/2011
2	TP protocol 04/2012 - 05/2010
2	Salvage Therapy 10/2011 - 03/2008
1	Segmental Mastectomy (Lumpectomy) 01/2024
1	Transplantation 11/2020
1	Hematopoietic Stem Cell Transplantation 11/2020
1	Art Therapy 01/2020
1	Molecular Targeted Therapy 01/2018
1	Treatment Delay 01/2018